Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
30,740,623
-
Share change
-
+403,631
-
Total reported value
-
$6,455,829
-
Put/Call ratio
-
26%
-
Price per share
-
$0.21
-
Number of holders
-
32
-
Value change
-
+$54,630
-
Number of buys
-
11
-
Number of sells
-
18
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2025
As of 31 Mar 2025,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,740,623 shares.
The largest 10 holders included
BVF INC/IL, Logos Global Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VR ADVISER, LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., Jefferies Financial Group Inc., GEODE CAPITAL MANAGEMENT, LLC, and UBS Group AG.
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.